logo

For the Inventor, By the Inventor

Kamiita-cho, Japan

Katsura Tottori

This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1996-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsura Tottori. Retrieved from https://idiyas.com/inventor/katsura-tottori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 42.9



Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 88(Granted Patents)


Location History:

  • Tokushima, JP (1996)
  • Tokushima-ken, JP (1996 - 1997)
  • Kamiita-cho, JP (2006 - 2015)
  • Kamita-Cho, JP (2015)
  • Kamiita, JP (2016)

Company Filing History:

goldMedal14 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents

Years Active: 1996-2016

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 9387207 - 5-HT1A receptor subtype agonist (2016-07-12),
2. 9089567 - Method of treating cognitive impairments and schizophrenias (2015-07-28),
3. 9006248 - [object Object] (2015-04-14),
4. 8722680 - Method of treating neurodegenerative diseases (2014-05-13),
5. 8680105 - Method of treating down's syndrome (2014-03-25),
6. 8642600 - Method of treating autism (2014-02-04),
7. 8623874 - Method of treating neurodegenerative diseases (2014-01-07),
8. 8604041 - Method of treating panic disorder (2013-12-10),
9. 8426423 - Method of treating Attention Deficit Hyper-Activity Disorder (2013-04-23),
10. 8030312 - 5-HT1A receptor subtype agonist (2011-10-04),
11. 7053092 - 5-HT1a receptor subtype agonist (2006-05-30),
12. 5656633 - Carbostyril derivatives and pharmaceutical compositions containing the (1997-08-12),
13. 5556857 - Disturbance-of-consciousness improving agent (1996-09-17),
14. 5506230 - Fatty emulsion (1996-04-09),

Title: Innovations of Katsura Tottori

Introduction

Katsura Tottori is a notable inventor based in Kamiita-cho, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders. With a total of 14 patents to his name, Tottori's work has had a profound impact on medical science.

Latest Patents

Among his latest patents, Tottori has developed a method for treating patients suffering from disorders associated with the 5-HT receptor subtype. This method involves the use of a carbostyril derivative or a salt thereof, represented by a specific formula. Another significant patent focuses on treating cognitive impairments and schizophrenias, utilizing a similar active ingredient to address central nervous system disorders.

Career Highlights

Katsura Tottori is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate and contribute to the field of medicine. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic methods.

Collaborations

Tottori has collaborated with notable colleagues, including Tetsuro Kikuchi and Tsuyoshi Hirose, who have contributed to his research and development efforts.

Conclusion

Katsura Tottori's innovative work in the pharmaceutical industry exemplifies the importance of research and development in treating complex medical conditions. His contributions continue to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…